Abstract
Tumor necrosis factor alpha (TNF-α) is a pro-inflammatory cytokine involved in the regulation of the immune system and potentially the progression of cervical neoplastic lesions. In this study, we aimed to explore the possible relationship between polymorphisms of the TNF-α gene and susceptibility to cervical cancer. The relationship between a single nucleotide polymorphism (SNP) in the TNF-α gene (rs1800629) and the risk of cervical cancer was evaluated in a total of 445 subjects with (n = 153), or without (n = 292) cancer. Genotyping was performed using a Taq-Man based real time PCR method. Logistic regression analysis showed that individuals with AG/AA genotypes had an increased risk of cervical cancer compared to those with a GG genotype (OR 3.79, 95% CI 2.4–5.7, < 0.001). Our findings demonstrated that a genetic variant in the TNF-α gene (rs1800629) was associated with increased level and risk of developing cervical cancer, suggesting its potential use as a genetic risk factor for cervical neoplasia.
Similar content being viewed by others
References
Lee S, Margolin K (2011) Cytokines in cancer immunotherapy. Cancers 3(4):3856–3893
Mantovani A, Dejana E (1989) Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 10(11):370–375
Newton K, Dixit VM (2012) Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 4(3):a006049
Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9(5):361
Strieter RM, Kunkel SL, Bone RC (1993) Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med 21(10 Suppl):S447-463
Ardizzoia A, Lissoni P, Brivio F, Tisi E, Perego M, Grassi M, Pittalis S, Crispino S, Barni S, Tancini G (1992) Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Regul Homeostat Agents 6(3):103–107
Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci 94(7):3195–3199
Raabe T, Bukrinsky M, Currie RA (1998) Relative contribution of transcription and translation to the induction of tumor necrosis factor-α by lipopolysaccharide. J Biol Chem 273(2):974–980
Kroeger KM, Carville KS, Abraham LJ (1997) The− 308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 34(5):391–399
Calhoun ES, McGovern RM, Janney CA, Cerhan JR, Iturria SJ, Smith DI, Gostout BS, Persing DH (2002) Host genetic polymorphism analysis in cervical cancer. Clin Chem 48(8):1218–1224
Govan VA, Constant D, Hoffman M, Williamson A-L (2006) The allelic distribution of-308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer 6(1):24
Babapour N, Mehramiz M, Rastgar Moghadam A, Behboodi N, Yousefi Z, Maftouh M, Talebian S, Khazaei M, Jafarian A, Sharifi-Sistani N, Avan A, Hasanzadeh M (2019) Association of TNF-308 G>A polymorphism located in tumor necrosis factor a with the risk of developing cervical cancer and results of pap smear. J Cell Biochem 120(4):5444–5448
Oladi M, Nohtani M, Avan A, Mirhafez SR, Tajbakhsh A, Ghasemi F, Asadi A, Elahdadi Salmani M, Mohammadi A, Hoseinzadeh L (2015) Impact of the C1431T polymorphism of the peroxisome proliferator activated receptor-gamma (PPAR-γ) gene on fasted serum lipid levels in patients with coronary artery disease. Ann Nutr Metab 66(2–3):149–154
Mehramiz M, Ghasemi F, Esmaily H, Tayefi M, Hassanian SM, Sadeghzade M, Sadabadi F, Moohebati M, Azarpazhooh MR, Parizadeh SM et al (2016) Interaction between a variant of CDKN2A/B-gene with lifestyle factors in determining dyslipidemia and estimated cardiovascular risk: a step toward personalized nutrition. Clin Nutr 37:254
Zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2(5):342
Hajeer AH, Hutchinson IV (2001) Influence of TNFα gene polymorphisms on TNFα production and disease. Hum Immunol 62(11):1191–1199
Duarte I, Santos A, Sousa H, Catarino R, Pinto D, Matos A, Pereira D, Moutinho J, Canedo P, Machado JC (2005) G-308A TNF-α polymorphism is associated with an increased risk of invasive cervical cancer. Biochem Biophys Res Commun 334(2):588–592
Jang WH, Yang Y-I, Yea SS, Lee YJ, Chun JH, Kim H-I, Kim MS, Paik K-H (2001) The-238 tumor necrosis factor-α promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 166(1):41–46
Liu L, Yang X, Chen X, Kan T, Shen Y, Chen Z, Hu Z (2012) Association between TNF-α polymorphisms and cervical cancer risk: a meta-analysis. Mol Biol Rep 39(3):2683–2688
Kirkpatrick A, Bidwell J, Van den Brule A, Meijer C, Pawade J, Glew S (2004) TNFα polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol Oncol 92(2):675–679
Stanczuk G, Sibanda E, Tswana S, Bergstrom S (2003) Polymorphism at the the− 308-promoter position of the tumor necrosis factor-alpha (TNF-α) gene and cervical cancer. Int J Gynecol Cancer 13(2):148–153
Wang N, Yin D, Zhang S, Wei H, Wang S, Zhang Y, Lu Y, Dai S, Li W, Zhang Q (2012) TNF-αlpha rs1800629 polymorphism is not associated with HPV infection or cervical cancer in the Chinese population. PLoS ONE 7(9):e45246
Funding
This study was supported by a grant from Mashhad University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no conflict of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Behboodi, N., Farazestanian, M., Rastgar-Moghadam, A. et al. Association of a variant in the tumor necrosis factor alpha gene with risk of cervical cancer. Mol Biol Rep 48, 1433–1437 (2021). https://doi.org/10.1007/s11033-021-06185-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-021-06185-4